Equipped with a blood test capable of predicting an individual’s response—or lack thereof—to the world’s largest drug class, Scipher Medicine is on its way to cracking the code of rheumatoid arthritis ...

Seven years ago, Northeastern graduate Susan Dina Ghiassian was the first employee of Scipher Medicine Corp., a precision medicine company co-founded by Northeastern professor Albert-László Barabási.

Crescendo Bioscience, creators of the Vectra DA blood test to predict the progression of rheumatoid arthritis (RA), is gaining market share in the United States, with its new parent company, Myriad ...

Please provide your email address to receive an email when new articles are posted on . If there was any question about whether rheumatologists would utilize an effective biomarker that can predict ...

SALT LAKE CITY, Nov. 09, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in precision medicine, announced that its Myriad Autoimmune business unit will present new data ...

(WNDU) - Rheumatoid arthritis is a progressive autoimmune disease that if untreated, can attack the joints and internal organs. There are medications that can help ...

Lake Charles, LA (KPLC) - Rheumatoid arthritis is a progressive autoimmune disease that if left untreated, can attack the joints and internal organs. There are medications that can help block the ...

Is there a possibility of having some type of rheumatoid arthritis (RA), even though it doesn’t show up clearly in the blood work? (My CRP level was 0.3, rheumatoid factor was 10, anti-CCP result was ...